Weighing the Evidence: A Pharmacy Approach to Stroke Prevention in Obese Patients with Non-Valvular Atrial Fibrillation
Atrial fibrillation (AF) is estimated to affect over 5 million people in the United States and is associated with a five-fold increase in the relative risk of stroke. Obesity is an independent risk factor for cardiovascular disease (CVD) and is also associated with increased risk of developing non-valvular AF (NVAF). Patients with comorbid NVAF and […]
Read MoreKeeping the Beat: Screening and Management of High-Risk Patients with Non-Valvular Atrial Fibrillation
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, projected to affect 12 million Americans by 2030. However, a significant number of AF cases, particularly non-valvular atrial fibrillation (NVAF) remain undiagnosed, putting patients at risk for severe cardiovascular (CV) complications, including increased risk of stroke. It is imperative that clinicians identify the symptomatology of […]
Read MoreKeeping the Beat: Screening and Management of High-Risk Patients with Non-Valvular Atrial Fibrillation
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, projected to affect 12 million Americans by 2030. However, a significant number of AF cases, particularly non-valvular atrial fibrillation (NVAF) remain undiagnosed, putting patients at risk for severe cardiovascular (CV) complications, including increased risk of stroke. This CME Outfitters OnDemand webcast will feature expert […]
Read MoreCardiology Education Hub
View the Cardiology Education Hub for resources and tools you can use in your practice and to educate your patients.
Read More